Results for
""Moxifloxacin""[mesh_terms]

Mycobacterium smegmatis strains genetically resistant to moxifloxacin emerge de novo from the moxifloxacin-surviving population containing high levels of superoxide, H₂O₂, hydroxyl radical, and Fe (II).

Avraneel Paul, Rashmi Ravindran Nair, Kishor Jakkala, Parthasarathi Ajitkumar

International journal of mycobacteriology 2022;11(2):150-158

A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis.

Bern-Thomas Nyang'wa, Catherine Berry, Emil Kazounis, Ilaria Motta, Nargiza Parpieva, Zinaida Tigay, Varvara Solodovnikova, Irina Liverko, Ronelle Moodliar, Matthew Dodd, Nosipho Ngubane, Mohammed Rassool, Timothy D McHugh, Melvin Spigelman, David A J Moore, Koert Ritmeijer, Philipp du Cros, Katherine Fielding

The New England journal of medicine 2022;387(25):2331-2343

Effects of Celecoxib on the QTc Interval: A Thorough QT/QTc Study.

Seokuee Kim, Hyeryeon Lee, Jae-Wook Ko, Jung-Ryul Kim

Clinical therapeutics 2020;41(11):2204-2218

Moxifloxacin-induced QT interval prolongation and torsades de pointes: a narrative review.

Fahadullah Khan, Mohammad Ismail, Qasim Khan, Zahid Ali

Expert opinion on drug safety 2018;17(10):1029-1039

A randomized, double-blind, crossover study of the effect of the fluoroquinolone moxifloxacin on glucose levels and insulin sensitivity in young men and women.

Christian R Juhl, Signe S Torekov, Bolette Hartmann, Josephine Burgdorf, Cecilie Knudsen, Anniek F Lubberding, Simon Veedfald, Jonas L Isaksen, Ruth Frikke-Schmidt, Thomas Mandrup-Poulsen, Jens J Holst, Jørgen K Kanters

Diabetes, obesity & metabolism 2022;25(1):98-109

Moxifloxacin in uncomplicated skin and skin structure infections.

Blair Jarvis, Richard B R Muijsers

Drugs 2002;62(6):967-73; discussion 974-5

Safety profile of oral and intravenous moxifloxacin: cumulative data from clinical trials and postmarketing studies.

Peter Ball, Ralf Stahlmann, Rolf Kubin, Shurjeel Choudhri, Robert Owens

Clinical therapeutics 2004;26(7):940-50

The Molecular Genetics of Fluoroquinolone Resistance in Mycobacterium tuberculosis.

Claudine Mayer, Howard Takiff

Microbiology spectrum 2016;2(4):MGM2-0009-2013

Biliary secretion of moxifloxacin in obstructive cholangitis and the non-obstructed biliary tract.

E G Hahn, D Schwab, M Grauer, S Mühldorfer

Alimentary pharmacology & therapeutics 2005;22(5):417-22

Vericiguat: A Randomized, Phase Ib, Placebo-Controlled, Double-Blind, QTc Interval Study in Patients with Chronic Coronary Syndromes.

Michael Böttcher, Hans-Dirk Düngen, Vasile Corcea, Frank Donath, Rainard Fuhr, Pim Gal, Gerd Mikus, Dietmar Trenk, Martin Coenen, Philippe Vieira Pires, Claudia Maschke, Antonios Othon Aliprantis, Nina Besche, Corina Becker

American journal of cardiovascular drugs : drugs, devices, and other interventions 2023;23(2):145-155

Moxifloxacin in Pediatric Patients With Complicated Intra-abdominal Infections: Results of the MOXIPEDIA Randomized Controlled Study.

Stefan Wirth, Sherif G S Emil, Arnis Engelis, Valeri Digtyar, Margarita Criollo, Carl DiCasoli, Heino Stass, Stefan Willmann, Richard Nkulikiyinka, Ulrike Grossmann

The Pediatric infectious disease journal 2019;37(8):e207-e213

Evaluating the effect of intravitreal triamcinolone-moxifloxacin during cataract surgery on central macular edema in patients with preexisting diabetic retinopathy.

Julia Angkadjaja, Joshua Chu, David I Sierpina, Jiahao Peng, Michael Rauser

Journal of cataract and refractive surgery 2021;46(9):1253-1259

Effect of hyperglycaemia in combination with moxifloxacin on cardiac repolarization in male and female patients with type I diabetes.

Jorg Taubel, Dominic Pimenta, Samuel Thomas Cole, Claus Graff, Jørgen K Kanters, A John Camm

Clinical research in cardiology : official journal of the German Cardiac Society 2022;111(10):1147-1160

Effects of enteral feeding on the oral bioavailability of moxifloxacin in healthy volunteers.

Olaf Burkhardt, Heino Stass, Uwe Thuss, Klaus Borner, Tobias Welte

Clinical pharmacokinetics 2005;44(9):969-76